|
시장보고서
상품코드
2140270
KI-67 항체 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 용도별, 최종사용자별, 숙주 유형별, 클론 성별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)KI-67 Antibody Market Size, Share, and Growth Analysis, By Product Type (Monoclonal Antibodies, Polyclonal Antibodies), By Application, By End User, By Host Species, By Clonality, By Distribution Channel, By Region - Industry Forecast 2026-2033 |
||||||
세계의 KI-67 항체 시장 규모는 2024년에 2억 8,470만 달러로 평가되었고, 2025년 3억 861만 달러에서 2033년까지 5억 8,838만 달러로 확대되어 예측 기간(2026-2033년)에 CAGR8.4%를 기록할 전망입니다.
전 세계 KI-67 항체 시장은 주로 종양학 진단 분야에서 정확한 증식성 바이오마커에 대한 수요 증가에 힘입어 성장하고 있습니다. KI-67은 종양의 침습성 평가, 치료 방침 결정 및 임상시험에서의 코호트 계층화에 필수적입니다. KI-67 스코어링이 암 치료 지침에 포함됨에 따라 해당 시장의 중요성은 더욱 높아지고 있습니다. 특히 표적 치료와 면역관문억제제의 부상과 함께, 치료 방침 결정에 있어 정량적인 바이오마커 데이터에 의존하는 임상의가 늘어남에 따라 고정밀 KI-67 분석법에 대한 수요는 계속해서 확대되고 있습니다. 또한, AI를 활용한 디지털 병리학의 영향으로 영상 분석 및 스코어링의 자동화가 진행되어 일관성이 향상되고, 검사실의 대규모 업무 부하 관리가 용이해지는 등 시장 환경이 변혁을 겪고 있습니다. 디지털 병리학에 대한 투자가 급증하고 있는 것은 검증된 KI-67 항체에 대한 수요를 뒷받침하고, 항체 개발 분야의 혁신을 촉진하고 있습니다.
전 세계 KI-67 항체 시장의 성장 요인
정밀 종양학에 대한 관심이 높아지는 가운데, 의료 종사자들이 종양의 침습성을 평가하고 맞춤형 치료 전략을 수립하기 위해 신뢰할 수 있는 마커를 찾음에 따라 KI-67 항체 분석법의 보급이 확대되고 있습니다. 이러한 추세에 따라 전 세계 연구 기관 및 진단실험실에서 이러한 시약의 적용 범위가 확대되고 있으며, 이는 고품질 제품에 대한 지속적인 수요를 창출하고 혁신적인 분석법 개발에 대한 투자를 촉진하고 있습니다. KI-67의 예후 마커로서의 역할을 강조하는 임상적 증거가 증가하고 있는 것은 표준 병리 검사 실무에 KI-67을 통합하는 데 박차를 가하고 있으며, 검사실의 역량 강화를 촉진하고 공급업체의 유통망 확장을 촉진하고 있습니다. 이러한 요인들이 결합되어 시장 성장을 강화하고 지속적인 연구 파트너십을 촉진하고 있습니다.
전 세계 KI-67 항체 시장의 제약 요인
고도의 정제 방법과 엄격한 품질 기준으로 인해 고순도 KI-67 항체의 비용이 높다는 점은 특히 개발도상 지역에서 볼 수 있는 예산이 제한된 검사실에서 그 보급에 큰 장벽이 되고 있습니다. 자금 면의 제약이 조달 결정에 결정적인 역할을 하기 때문에 많은 기관은 더 저렴한 대체 마커를 사용하거나 검사 도입을 연기할 가능성이 있습니다. 그 결과, 전반적인 수요가 감소하여 시장 성장이 저해될 것입니다. 이러한 재정적 부담으로 인해 전문적인 시약보다 필수적인 진단 도구가 우선시되는 경우가 많으며, KI-67 항체의 임상적 중요성에도 불구하고 그 광범위한 보급이 더욱 저해되고, 소규모 연구 기관이 첨단 진단 기술에 대한 투자를 주저하는 요인이 되고 있습니다.
세계 KI-67 항체 시장 동향
전 세계 KI-67 항체 시장에서는 정밀 의학에 대한 관심이 높아지는 것을 배경으로, 개인 맞춤형 암 진단을 향한 뚜렷한 추세가 나타나고 있습니다. 검사 기관에서는 치료 프로토콜의 최적화, 치료 반응 평가, 그리고 종양의 침습성에 기반한 환자 분류를 위해 KI-67 항체의 도입이 점점 더 확대되고 있습니다. 이러한 패러다임의 변화에 따라 제조업체들은 혁신을 도모하여 특이성이 높고 재현성이 뛰어난 항체 클론을 제조해야 할 필요가 있습니다. 또한, 기술 지원 강화를 통해 의료 서비스 제공업체와의 협력이 촉진되면서, 궁극적으로는 기존의 병리 검사실을 넘어선 시장으로의 진출이 진행되고 있습니다. 그 결과, 전 세계적인 유통 채널과 교육 프로그램이 확대되고 있으며, KI-67 항체는 맞춤형 암 치료 전략에서 매우 중요한 도구로서의 입지를 확립해 가고 있습니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 KI-67 항체 시장 규모 : 제품 유형별
세계의 KI-67 항체 시장 규모 : 용도별
세계의 KI-67 항체 시장 규모 : 최종사용자별
세계의 KI-67 항체 시장 규모 : 숙주 유형별
세계의 KI-67 항체 시장 규모 : 클론 성별
세계의 KI-67 항체 시장 규모 : 유통 채널별
세계의 KI-67 항체 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
LSH 26.10.13Global Ki-67 Antibody Market size was valued at USD 284.7 Million in 2024 and is poised to grow from USD 308.61 Million in 2025 to USD 588.38 Million by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).
The global Ki-67 antibody market is primarily driven by the increasing need for accurate proliferative biomarkers in oncology diagnostics. Ki-67 is vital for evaluating tumor aggression, directing therapy, and cohort stratification in clinical trials. The integration of Ki-67 scoring into cancer treatment guidelines has heightened its market significance. As more clinicians rely on quantitative biomarker data for treatment decisions, especially with the rise of targeted therapies and immune checkpoint inhibitors, the demand for precise Ki-67 assays continues to grow. Moreover, the influence of AI-driven digital pathology is transforming the landscape by automating image analysis and scoring, enhancing consistency, and facilitating larger workload management in labs. This surge in digital pathology investments boosts demand for validated Ki-67 antibodies and encourages innovation in antibody development.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Ki-67 Antibody market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Ki-67 Antibody Market Segments Analysis
Global ki-67 antibody market is segmented by product type, application, end user, host species, clonality, distribution channel and region. Based on product type, the market is segmented into Monoclonal Antibodies, Polyclonal Antibodies, Recombinant Antibodies and Others. Based on application, the market is segmented into Immunohistochemistry, Western Blotting, Flow Cytometry and Others. Based on end user, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Clinical Laboratories and Others. Based on host species, the market is segmented into Rabbit, Mouse and Others. Based on clonality, the market is segmented into Monoclonal and Polyclonal. Based on distribution channel, the market is segmented into Direct Sales, Laboratory Distributors and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Ki-67 Antibody Market
The rising focus on precision oncology is propelling the widespread usage of Ki-67 antibody assays as healthcare professionals look for dependable markers to assess tumor aggressiveness and inform tailored treatment strategies. This trend enhances the applicability of these reagents in research and diagnostic labs globally, driving sustained demand for high-quality products and encouraging investment in the development of innovative assays. Increasing clinical evidence that highlights Ki-67's role as a prognostic marker supports its incorporation into standard pathology practices, motivating laboratories to enhance their capabilities and suppliers to expand their distribution networks, which collectively strengthens market growth and promotes ongoing research partnerships.
Restraints in the Global Ki-67 Antibody Market
The high costs associated with high-purity Ki-67 antibodies, due to intensive purification methods and rigorous quality standards, pose significant barriers to their widespread adoption, especially in budget-restricted laboratories found in developing regions. As financial limitations play a crucial role in procurement choices, many institutions may choose to utilize more affordable alternative markers or postpone the implementation of assays, ultimately diminishing overall demand and hindering market growth. This financial strain often leads to a preference for essential diagnostic tools over specialized reagents, further obstructing the wider acceptance of Ki-67 antibodies despite their clinical importance, and deterring smaller research entities from investing in advanced diagnostic technologies.
Market Trends of the Global Ki-67 Antibody Market
The Global Ki-67 Antibody market is witnessing a significant trend towards personalized oncology diagnostics, driven by the increasing focus on precision medicine. Laboratories are increasingly incorporating Ki-67 antibodies to refine treatment protocols, evaluate therapeutic responses, and categorize patients according to tumor aggressiveness. This paradigm shift compels manufacturers to innovate and produce highly specific, reproducible antibody clones. Furthermore, it promotes collaboration with healthcare providers through enhanced technical support, ultimately broadening market reach beyond traditional pathology labs. As a result, global distribution channels and training initiatives are expanding, positioning Ki-67 antibodies as pivotal tools in personalized cancer care strategies.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global KI-67 Antibody Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Monoclonal Antibodies
- Polyclonal Antibodies
- Recombinant Antibodies
- Others
Global KI-67 Antibody Market Size by Application & CAGR (2026-2033)
- Market Overview
- Immunohistochemistry
- Western Blotting
- Flow Cytometry
- Others
Global KI-67 Antibody Market Size by End User & CAGR (2026-2033)
- Market Overview
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Clinical Laboratories
- Others
Global KI-67 Antibody Market Size by Host Species & CAGR (2026-2033)
- Market Overview
- Rabbit
- Mouse
- Others
Global KI-67 Antibody Market Size by Clonality & CAGR (2026-2033)
- Market Overview
- Monoclonal
- Polyclonal
Global KI-67 Antibody Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Direct Sales
- Laboratory Distributors
- Others
Global KI-67 Antibody Market Size & CAGR (2026-2033)
- North America (Product Type, Application, End User, Host Species, Clonality, Distribution Channel)
- US
- Canada
- Europe (Product Type, Application, End User, Host Species, Clonality, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Application, End User, Host Species, Clonality, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Application, End User, Host Species, Clonality, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Application, End User, Host Species, Clonality, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Abcam plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cell Signaling Technology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Techne Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Santa Cruz Biotechnology, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GeneTex, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Proteintech Group, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novus Biologicals LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- OriGene Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Creative Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Atlas Antibodies AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Rockland Immunochemicals, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GenScript Biotech Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boster Biological Technology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BioLegend, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Miltenyi Biotec B.V. & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- RayBiotech Life, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cusabio Technology LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
